Thursday, November 21st, 2024

Renounceable Non-Underwritten Rights Issue of GS Holdings Limited – Key Investor Details

Key Points and Investor Actions:

  1. Rights Issue Overview:

    • GS Holdings Limited is offering a renounceable non-underwritten rights issue of up to 570,888,708 new ordinary shares at an issue price of S$0.015 per Rights Share. The ratio is two (2) Rights Shares for every one (1) existing ordinary share held as of the record date.
  2. Discount Information:

    • The issue price represents an 11.76% discount to the volume-weighted average price of S$0.017.
  3. Dates to Note:

    • Record Date: 11 September 2024, 5:00 p.m.
    • Last Date for Acceptance and Payment for Rights Shares: 30 September 2024.
    • Trading of Rights Shares Commencement: 8 October 2024.
  4. Actions for Shareholders:

    • Eligible shareholders can subscribe for their provisional allotments by the deadline of 30 September 2024.
    • Excess Rights Shares can also be applied for during the rights issue period.
  5. Allotment and Listing:

    • Rights Shares have been allotted and listed on SGX-ST on 8 October 2024, with trading commencing the same day.

Special Notes for Investors:

  • Foreign shareholders will not be entitled to participate in this rights issue unless they have provided an address in Singapore prior to the record date.
  • The Rights Shares rank pari passu with existing shares, except for any dividends or distributions declared before the rights issue.

Investors should be aware of these timelines and ensure their actions align with the key dates to maximize their benefits from the rights issue.

Notice of Final Dividend for FY2024: Key Dates and Payment Details for Civmec Limited Shareholders

Key Facts from the Report Dividend Declaration: Civmec Limited has declared a final dividend of A$0.035 per share for the financial year ended 30 June 2024. Record Date: Shareholders on record as of 5:00...

Clearbridge Health Limited Receives SGX-ST Approval for 1.28 Billion Rights Share Issuance

Clearbridge Health’s Strategic Rights Issue Receives Regulatory Green Light Clearbridge Health’s Strategic Rights Issue Receives Regulatory Green Light Clearbridge Health Limited has achieved a significant milestone as it announces the receipt of the listing...

Japfa Ltd Amended Notice of Book Closure: Once-Off Interim Dividend for 2024

Japfa Ltd has announced a one-time, tax-exempt interim dividend of 1 Singapore cent per share for the financial year ending 31 December 2024. Record Date for Entitlement: 6 November 2024, 5:00 p.m. (Singapore time)....